IP Verse

Use Of Long Acting Glp 1 Peptides - EP2866825

PATENT ANALYSIS

Patent Details

Grant Date
Apr 8, 2020
Company
NOVO NORDISK A/S
Oppositions

GALENICUM HEALTH S.L.U.

GENERICS [UK] LIMITED

TEVA PHARMACEUTICAL INDUSTRIES LTD

More patents of Novo Nordisk A/S

EP3488857

EP3542790

EP3746111

Want to monitor this patent?

Feel free to send us a message here and we will get back to you